Suguru Kadomoto Selected Research

cafestol

12/2021	Anti-proliferative and anti-migratory properties of coffee diterpenes kahweol acetate and cafestol in human renal cancer cells.
1/2019	Coffee diterpenes kahweol acetate and cafestol synergistically inhibit the proliferation and migration of prostate cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Suguru Kadomoto Research Topics

Disease

15	Prostatic Neoplasms (Prostate Cancer) 11/2022 - 01/2018
10	Neoplasms (Cancer) 06/2022 - 01/2018
7	Neoplasm Metastasis (Metastasis) 05/2021 - 02/2017
2	COVID-19 07/2022 - 04/2022
2	Urologic Neoplasms (Urological Cancer) 07/2022 - 04/2022
2	Neutropenia 07/2022 - 01/2021
2	Carcinoma (Carcinomatosis) 11/2021 - 01/2019
2	Inflammation (Inflammations) 08/2021 - 07/2020
1	Malnutrition (Nutritional Deficiencies) 07/2022
1	Febrile Neutropenia 07/2022
1	Hemorrhage 06/2022
1	Kidney Neoplasms (Kidney Cancer) 12/2021
1	Lymphocele 09/2021
1	Sarcopenia 05/2021
1	Pelvic Organ Prolapse 01/2021
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2021
1	Hypertension (High Blood Pressure) 07/2020
1	Disease Progression 02/2020
1	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2020
1	Urachal cancer 08/2019
1	Adenocarcinoma 11/2018
1	Lymphatic Metastasis 05/2018
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2018
1	Breast Neoplasms (Breast Cancer) 02/2017
1	Urinary Tract Infections (Urinary Tract Infection) 01/2015
1	Disseminated Intravascular Coagulation 01/2015

Drug/Important Bio-Agent (IBA)

5	LigandsIBA 11/2022 - 03/2018
4	ChemokinesIBA 08/2021 - 03/2018
4	cabazitaxel FDA Link 05/2021 - 03/2018
3	CC ChemokinesIBA 11/2022 - 05/2018
3	AndrogensIBA 01/2021 - 01/2018
3	Androgen Receptors (Androgen Receptor)IBA 01/2021 - 03/2018
2	Coffee FDA Link 12/2021 - 01/2019
2	kahweol acetateIBA 12/2021 - 01/2019
2	cafestolIBA 12/2021 - 01/2019
2	DiterpenesIBA 12/2021 - 01/2019
2	Docetaxel (Taxotere)FDA Link 05/2021 - 01/2019
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 08/2019
1	Biomarkers (Surrogate Marker)IBA 11/2022
1	Prostate-Specific Antigen (Semenogelase)IBA 11/2022
1	pembrolizumabIBA 04/2022
1	COVID-19 VaccinesIBA 04/2022
1	VaccinesIBA 04/2022
1	kahweolIBA 12/2021
1	Pharmaceutical PreparationsIBA 12/2021
1	PlatinumIBA 11/2021
1	Chemotactic FactorsIBA 08/2021
1	CytokinesIBA 08/2021
1	indium-bleomycinIBA 01/2021
1	Polytetrafluoroethylene (Teflon)FDA Link 01/2021
1	pegfilgrastim (Neulasta)FDA Link 01/2021
1	taxaneIBA 01/2021
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2021
1	FlavonoidsIBA 01/2021
1	2'-hydroxyflavanoneIBA 01/2021
1	Etoposide (VP 16)FDA LinkGeneric 01/2021
1	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 07/2020
1	Proteins (Proteins, Gene)FDA Link 07/2020
1	Antihypertensive Agents (Antihypertensives)IBA 07/2020
1	Testosterone (Sustanon)FDA Link 01/2020
1	Tumor Biomarkers (Tumor Markers)IBA 08/2019
1	Gemcitabine FDA Link 08/2019
1	enzalutamideIBA 05/2019
1	Abiraterone AcetateIBA 05/2019
1	Therapeutic UsesIBA 05/2019
1	caffeic acidIBA 01/2019
1	Caffeine (No Doz)FDA LinkGeneric 01/2019
1	trigonellineIBA 01/2019
1	CA-19-9 Antigen (CA 19-9 Antigen)IBA 01/2019
1	Chlorogenic AcidIBA 01/2019
1	CarbohydratesIBA 01/2019
1	Phosphopyruvate Hydratase (Enolase)IBA 11/2018
1	big gastrinIBA 11/2018
1	Peptides (Polypeptides)IBA 11/2018
1	Hormones (Hormone)IBA 11/2018
1	Somatostatin Receptors (Somatostatin Receptor)IBA 11/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2018
1	p38 Mitogen-Activated Protein KinasesIBA 05/2018
1	CCR4 ReceptorsIBA 02/2017
1	ThrombomodulinIBA 01/2015
1	Dacarbazine (DIC)FDA LinkGeneric 01/2015

Therapy/Procedure

9	Drug Therapy (Chemotherapy) 07/2022 - 01/2018
8	Castration 11/2022 - 03/2018
8	Therapeutics 07/2022 - 11/2018
3	Combination Drug Therapy (Combination Chemotherapy) 11/2021 - 08/2019
2	Oral Administration 01/2021 - 01/2019
1	Hand Hygiene 07/2022
1	Nephrectomy 06/2022
1	Lymph Node Excision (Lymph Node Dissection) 09/2021
1	Brachytherapy 01/2020
1	Radiotherapy 08/2019
1	Neoadjuvant Therapy 01/2018